Markku O. Pentikäinen
Markku O. Pentikäinen publishes mostly in Immunology, Cardiology and Cardiovascular Medicine and Surgery, on topics such as Atherosclerosis and Cardiovascular Diseases, Transplantation: Methods and Outcomes and Cardiovascular Function and Risk Factors.
- World rank
- #599,952 of 7,710,434 ranked researchers
- Rank in Finland
- #3,605 of 37,370
- Works
- 91
- Citations
- 5.2k
- Citations per work
- 57.1
What does Markku O. Pentikäinen research?
Markku O. Pentikäinen's work is mostly in Medicine (32%), Immunology and Microbiology (16%), Biochemistry, Genetics and Molecular Biology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else3841.7%
- Health Sciences2932.3%
- Medicine2932.3%
- Life Sciences2426.0%
- 1Immunology16% of their works
- 2Cardiology and Cardiovascular Medicine13% of their works
- 3Surgery13% of their works
- 4Epidemiology6% of their works
- 5Molecular Biology6% of their works
- 6Cancer Research5% of their works
Research topics
- Atherosclerosis and Cardiovascular Diseases
- Transplantation: Methods and Outcomes
- Cardiovascular Function and Risk Factors
- Cardiovascular Disease and Adiposity
- Adipokines, Inflammation, and Metabolic Diseases
- Lipoproteins and Cardiovascular Health
- Protease and Inhibitor Mechanisms
- Antioxidant Activity and Oxidative Stress
Which keywords describe Markku O. Pentikäinen's research?
The keywords of their largest research topics: Inflammation, Atherosclerosis, Obesity, Immune Response, Oxidized LDL, Cardiovascular Disease, C-Reactive Protein and Rejection.
- Oxidative Stress
- Antioxidants
- Insulin Resistance
- Adipose Tissue
- Epicardial Fat
- Chamber Quantification
- Rejection
- Cardiovascular Disease
- Immune Response
- Atherosclerosis
- Inflammation
- Obesity
- Oxidized LDL
- C-Reactive Protein
- Transplantation
- Echocardiography
- Perivascular Adipose Tissue
- Cholesterol-lowering
- Statins
- Matrix Metalloproteinases
- Tissue Inhibitors of Metalloproteinases
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Inflammation504 topics
- Atherosclerosis413 topics
- Obesity293 topics
- Immune Response231 topic
- Oxidized LDL231 topic
- Cardiovascular Disease192 topics
- C-Reactive Protein182 topics
- Rejection111 topic
- Transplantation111 topic
- Chamber Quantification101 topic
- Echocardiography101 topic
- Epicardial Fat101 topic
- Perivascular Adipose Tissue101 topic
- Adipose Tissue91 topic
- Cholesterol-lowering91 topic
- Insulin Resistance91 topic
- Statins91 topic
- Antioxidants81 topic
- Matrix Metalloproteinases81 topic
- Oxidative Stress81 topic
- Tissue Inhibitors of Metalloproteinases81 topic
Where does Markku O. Pentikäinen work?
Markku O. Pentikäinen's main affiliation in the publication record is Wihuri Research Institute, Finland.
How many publications and citations does Markku O. Pentikäinen have?
OpenAlex counts 91 works and 5,196 citations for Markku O. Pentikäinen, an h-index of 37, ranking #599,952 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Markku O. Pentikäinen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.